CME Group Inc. (CME) Fair Value 2026

CME · Security & Commodity Brokers, Dealers, Exchanges & Services ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

8.9 /10

32 fundamental signals · 12 models active

Value Trap Risk

(—/100)

Quick Summary — As of 2026-07-13, CME Group Inc. (CME) trades at $245.10, approximately 37% above CirclFi’s Bayesian DCF fair value of $178.69. QOC: 8.9/10. 12/13 models active.

Key Facts

Ticker
CME
Price
$245.10
Quality Score
8.9/10
Value Trap Risk
—/100
Models Active
12/13
Last Updated
Strength: Quality Score of 8.9/10 indicates strong fundamentals
Risk: Majority of models suggest overvaluation

Valuation Matrix

12 Intrinsic Value Models vs. Current Price ($245.10)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
High Conviction
$178.69 -27.1%
Earnings Power Value
High Conviction
$63.09 -74.3%
CUCE Ensemble
Low Conviction
$188.28 -23.2%
First Chicago
High Conviction
$174.73 -28.7%

Unlock the Full Matrix

Access 8 additional models including EROIC Spread, Markov DDM, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 12 Models →

Cancel anytime · No contracts · Instant access

What Is CME Group Inc. (CME) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, the balance of valuation evidence tilts cautious on CME Group Inc. at its current price of $245.10. The composite intrinsic value is estimated at $260.26 (+6.2% average return), with 8 models flagging overvaluation risk. The most optimistic model, Markov DDM, places fair value at $1,157.39 (+372.2%), while EPV — the most conservative — estimates $63.09 (-74.3%). This +446.5% gap reflects genuine analytical uncertainty about CME Group Inc.'s intrinsic worth.

What Do the Models Say About CME?

12 of 13 models are currently active for CME. Of these, 2 models suggest upside while 10 models suggest overvaluation. The Bayesian DCF estimates CME's intrinsic value at $178.69, implying -27.1% downside from the current price. See which stocks rank higher →

How Does CME Rank in Security & Commodity Brokers, Dealers, Exchanges & Services?

Among 14 Security & Commodity Brokers, Dealers, Exchanges & Services stocks, CME ranks #4 by Quality of Company score. CirclFi's QOC score of 8.9/10 evaluates 32 fundamental signals. A score of 8.9 places CME in the top tier.

CME Group Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is CME a Value Trap?

The Value Trap algorithm is not active for CME. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

12 of 13 models are active for CME Group Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, CME Group Inc.'s fundamental quality profile registers 8.9/10. This robust score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

The gap between the most bullish and bearish model spans +446.5% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every CME valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across CME's 12 active models, average confidence is 47%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy CME Group Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Security & Commodity Brokers, Dealers, Exchanges & Services Stocks Should You Also Analyze?

8 related Security & Commodity Brokers, Dealers, Exchanges & Services stocks with 13-model coverage

Read investment analysis: CBOE · TW · MRX · SNEX · ICE

Frequently Asked Questions About CME Group Inc.

What is CME Group Inc.'s intrinsic value in 2026?

Based on CirclFi's 13-model analysis, CME Group Inc. (CME) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $178.69. The Quality of Company score is 8.9/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is CME overvalued or undervalued right now?

At $245.10, 2 of 12 active models suggest CME may be undervalued, while 10 indicate potential overvaluation. The assessment depends on which methodology best fits CME Group Inc.'s business model in Security & Commodity Brokers, Dealers, Exchanges & Services.

What does a Quality of Company score of 8.9 mean for CME?

CME Group Inc.'s QOC of 8.9/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on CME?

CirclFi analyzes CME with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 12 of 13 are active for this stock. Read the full methodology →

Is CME a value trap in 2026?

CirclFi's Value Trap algorithm does not have sufficient data for CME at this time. Browse stocks by value-trap risk →

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 12 mathematical frameworks give you clarity on CME.

Unlock All 12 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access